GE Healthcare late last week announced that it has reached an agreement to acquire Applied Precision, Inc., a supplier of cellular imaging technologies for the cell biology and biomedical research sectors. The acquisition of Applied Precision will allow GE Healthcare to expand its offering of products and services for pharmaceutical and life science research.
Applied Precision develops and manufactures high-resolution and super-resolution microscopy instruments with software and data visualization tools that together provide scientists with detailed information on the structure and behavior of live and fixed cells. Its proprietary technologies complement GE Healthcare’s IN Cell Analyzer systems, which are used for high-throughput sub-cellular analysis in cell biology research.
GE Healthcare plans to retain the Applied Precision facility in Issaquah, Washington state. The acquisition is consistent with GE's strategy to invest in high-technology, innovative businesses that deliver strong top-line growth and expanded margins.
The acquisition, which is subject to customary closing conditions including regulatory approvals, is expected to close during the second quarter of 2011. Financial terms of the deal were not disclosed.